Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "The RIGHT Choice Trial - 1L Ribociclib + ET vs. Combination Chemo in Aggressive HR+/HER2- Advanced Breast Cancer"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Hamdy Azim
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Hamdy Azim
391 views
November 14, 2023
Comments 0
Login to view comments.
Click here to Login
Breast